TB-500 2mg — Vial Spec, Reconstitution Math & COA

TB-500 2mg Vial Overview and Laboratory Sizing Fit

In analytical and preclinical laboratory settings, a 2mg vial of tb-500 delivers a compact, highly controllable unit of lyophilized peptide designed for targeted experimental series. TB-500, a synthetic peptide sequence corresponding to the active region of naturally occurring Thymosin Beta-4 (Tβ4), is widely investigated as a regeneration peptide in tissue repair models. Containing precisely 2.0 milligrams of active peptide mass along with a bio-inert bulking agent (typically mannitol or trehalose), the 2mg format is specifically tailored for research teams conducting short-duration rodent studies, acute cell culture assays, or initial concentration-response screens where reconstituting larger bulk quantities would introduce unnecessary risk of peptide degradation from prolonged storage.

While PX1 Research maintains a core inventory focusing on higher-capacity fills such as our TB-500 10mg vial to accommodate extended multi-week protocols, understanding the physical dynamics and mathematical reconstitution profile of a 2mg mass remains essential for lab technicians. Ordering smaller 2mg units allows investigative teams to minimize aliquot waste, optimize storage footprint in ultra-low temperature freezers, and execute tightly isolated trial cohorts. Whether exploring early-stage endothelial migration or measuring actin sequestration dynamics, researchers choosing or evaluating the 2mg specification benefit from precise dosage control per analytical batch across our full catalog of research peptides.

Molecular Identity and Preclinical Mechanisms of Action

TB-500 represents the bioactive region (specifically amino acids 17–23, N-acetylated and C-amidated in shortened constructs, or full-length 43-amino-acid synthetic analogs) of Thymosin Beta-4. Preclinical studies suggest that the primary biochemical function of this sequence centers on monomeric actin (G-actin) sequestration. By binding to G-actin in a 1:1 stoichiometric ratio, TB-500 prevents spontaneous actin polymerization into microfilaments (F-actin), maintaining a dynamic intracellular pool of actin monomers necessary for rapid cellular remodeling and directional cell migration.

In vitro data indicate that this actin-regulating activity directly influences cell motility, particularly in dermal fibroblasts, vascular endothelial cells, and myoblasts. Furthermore, rodent models evaluating soft-tissue trauma demonstrate that TB-500 administration correlates with up-regulated expression of matrix metalloproteinases (MMPs), promotion of early-stage angiogenesis via vascular endothelial growth factor (VEGF) cascades, and enhanced structural flexibility during muscle-fiber recovery. By accelerating cell migration into ischemic or damaged microenvironments without triggering excessive fibrotic scarring, TB-500 remains a foundational compound for investigating soft-tissue regeneration, microvascular sprouting, and extracellular matrix (ECM) turnover.

Reconstitution Mathematics: 1mL, 2mL, and 3mL Diluent Protocols

Accurate reconstitution is critical to maintaining experimental consistency and avoiding stock concentration errors during micro-pipetting. When working with a 2mg lyophilized cake, researchers must calculate the resulting concentration (mg/mL and µg/µL) based on the precise volume of sterile diluent added. Bacteriostatic Water (0.9% benzyl alcohol preserved) or sterile 0.9% sodium chloride for laboratory use are standard diluents, selected depending on whether the working solution will be utilized over multiple days or immediately introduced into cell cultures.

The fundamental concentration formula is expressed as: Concentration (mg/mL) = Total Peptide Mass (mg) / Total Diluent Volume (mL). Below are the explicit calculations for reconstituting a 2mg tb-500 vial:

• 1.0 mL Diluent Addition: 2.0 mg / 1.0 mL = 2.0 mg/mL (or 2.0 µg/µL). This high-density concentration is ideal for small micro-injection volumes in focal rodent models, minimizing fluid volume burden in target tissue beds.

• 2.0 mL Diluent Addition: 2.0 mg / 2.0 mL = 1.0 mg/mL (or 1.0 µg/µL). This standard 1:1 ratio simplifies dose-calculation math significantly, allowing laboratory personnel to aliquot 100 µL to achieve exactly 100 µg of active peptide.

• 3.0 mL Diluent Addition: 2.0 mg / 3.0 mL = 0.667 mg/mL (or approximately 0.67 µg/µL). This diluted working stock is frequently preferred for multi-well in vitro assays where larger pipette volumes are necessary to ensure volumetric accuracy across repeated microplate wells.

Researchers verifying complex diluent ratios or combining multi-vial protocol series should utilize our interactive reconstitution calculator to eliminate manual calculation errors prior to laboratory execution.

Aliquot Planning, Handling, and Long-Term Thermal Stability

Lyophilized TB-500 displays excellent physical stability when stored under proper thermal conditions. Unreconstituted 2mg vials should be kept in a desiccated storage environment at -20°C for routine short-to-medium term storage, or at -80°C for multi-year archive stability. Under these sub-zero conditions, the lyophilizate resists hydrolytic degradation and peptide aggregation.

Once reconstituted, peptide stability drops significantly due to aqueous hydrolysis. Reconstituted working solutions using bacteriostatic water maintain analytical integrity at 2°C to 8°C for up to 28 days. If reconstituted in non-preserved sterile 0.9% saline or sterile water for single-use in vitro cell culture, the solution must be utilized immediately or aliquoted and frozen to prevent microbial growth and rapid degradation.

To maximize stability and avoid destructive freeze-thaw cycles—which mechanically shear peptide bonds—investigators should aliquot the freshly reconstituted stock into single-use polypropylene low-binding microcentrifuge tubes. Aliquots designated for future testing phases should be snap-frozen in liquid nitrogen or an ethanol-dry ice bath and stored at -80°C. Never subject a single aliquot to more than one freeze-thaw cycle.

Selecting the Optimal Vial Mass: 2mg vs. 10mg Protocols

Determining whether a 2mg or 10mg vial configuration is appropriate depends on experimental scale, study duration, and subject model size. A 2mg vial serves as an efficient format for acute, single-phase exploratory assays, such as evaluating endothelial cell tubulogenesis across a 48-hour window or screening baseline cell migration velocities. It prevents the financial and analytical degradation costs associated with reconstituting a large mass of peptide that cannot be consumed within its aqueous stability window.

Conversely, long-term animal studies tracking muscle-fiber recovery over 4–8 weeks typically require substantial cumulative peptide mass. In these scenarios, utilizing larger fill sizes like the PX1 TB-500 10mg vial offers superior unit economics, reduces container-closure interaction risks, and minimizes lot-to-lot variance across extended longitudinal experimental blocks. Research teams can consult our wider research library hub to examine study design protocols and determine total mass requirements before placing orders.

Analytical Quality Control: HPLC, Mass Spectrometry, and Lot-Matched COAs

At PX1 Research, analytical rigor underpins every manufacturing lot. Peptide research compounds produced for laboratory use must undergo strict quality assurance steps to ensure experimental reproducibility and eliminate confounding variables caused by synthesis impurities, residual solvents, or bacterial contaminants.

Every batch of TB-500 undergoes High-Performance Liquid Chromatography (HPLC) to verify chemical purity levels, targeting >99.0% chromatographic purity. Electrospray Ionization Mass Spectrometry (ESI-MS) is simultaneously performed to verify exact molecular weight and confirm sequence identity against theoretical mass profiles. Furthermore, because TB-500 is extensively studied in vascular and cell migration models sensitive to pyrogens, lot-specific bacterial endotoxin testing (LAL assay) is enforced to ensure endotoxin levels remain strictly below regulatory thresholds (<0.01 EU/µg).

Laboratory directors and principal investigators can independently verify every fill size by accessing our public COA repository, where lot-matched analytical documentation—including raw HPLC chromatograms and mass spectra—is freely available for download.

Comparative Analysis: Regenerative Peptide Classes in Preclinical Models

TB-500 belongs to a specialized class of tissue-modifying research compounds evaluated for structural repair, cell survival, and matrix organization. When designing comprehensive soft-tissue or musculoskeletal models, researchers frequently compare or combine TB-500 with complementary peptide agents to evaluate synergistic signaling cascades.

For instance, while TB-500 operates primarily through G-actin sequestration and cell migration pathways, BPC-157 5mg functions largely through nitric oxide synthesis modulation, early focal adhesion kinase activation, and VEGFR2 pathway up-regulation. Similarly, GHK-Cu acts as a copper-binding tripeptide that regulates collagen synthesis, antioxidant enzyme expression, and gene transcription in connective tissues. Evaluating these compounds side-by-side in vitro allows research teams to map distinct regulatory nodes within the broader cascade of soft-tissue remodeling and microvascular renewal.

Preclinical Applications: Soft-Tissue Repair and Microvascular Assays

Preclinical investigation into TB-500 spans several major biophysical domains:

• Endothelial Cell Migration & Angiogenesis: In vitro scratch assays and matrigel tube-formation models demonstrate that TB-500 exposure increases human umbilical vein endothelial cell (HUVEC) migration rate, supporting microvascular network assembly without promoting hyper-permeability.

• Muscle Fiber Regeneration: In rodent models of ischemic or laceration-induced skeletal muscle injury, systemic or local administration of synthetic Thymosin Beta-4 fragments promotes myoblast proliferation and down-regulates inflammatory cytokine release (such as TNF-alpha), enhancing functional tissue flexibility during structural recovery.

• Dermal & Tendon Repair: Animal studies investigating collagen organization in transected tendon models indicate that actin-sequestration support improves tensile strength alignment by promoting early fibroblast migration while preventing excess type-III collagen cross-linking.

All investigations must be restricted strictly to in vitro, ex vivo, or animal model systems under institutional animal care guidelines.

PX1 Research Supply Standards and Institutional Procurement

PX1 Research operates as a premier USA-based supplier dedicated exclusively to laboratory research compounds. All peptides are synthesized in state-of-the-art, GMP-compliant facilities and tested through an independent ISO 17025 accredited analytical laboratory to guarantee uncompromised purity and batch consistency.

To support high-throughput laboratory schedules, PX1 dispatches orders same-day (Monday through Friday) directly from our strategically located fulfillment centers in California and Arizona. Institutional procurement departments, academic laboratories, and contract research organizations requiring dedicated batch reservations or custom bulk packaging for high-volume research can access our streamlined wholesale supply portal to coordinate enterprise lab accounts and dedicated logistics.